PRINCIPAL CONSULTANT

John C Deavin B.Pharm,MRPharmS,FTOPRA,MCMI

POSITIONS HELD

1962-1966                                           Research Analyst.

Wellcome Foundation Ltd.

1966-1970                                           Head of Codex Laboratory

Royal Pharmaceutical Society of Great Britain.

1970-1972                                           Product Registrar – Pharmaceuticals

Eli Lilly & Co. Ltd.

1972 -1977                                          New Products Manager

WR Warner & Co. Ltd.

Warner Lambert.

1977 -1984                                          Registration Manager

E-Merck Ltd. Alton, Hampshire.

1984-1993                                           Business Development and Regulatory Affairs Manager.

E Merck Pharmaceuticals (Division of Merck Ltd.).

1993-1994                                           Regulatory Affairs Manager

Merck- Lipha.

1994-1995                                           Regulatory Affairs Manager Lederle Laboratories (Hants.)

1995-1996                                           Regulatory Affairs Manager Medeva Group Development (Leatherhead)

1996 – 1997                                         Head of Regulatory Affairs (Marketed Vaccines) Medeva (Leatherhead)

1997 – 1998                                         Head of Regulatory Operations Medeva Group Development.

1998 – 1999                                        Senior Regulatory Affairs Consultant Medeva Development.

2000-Present                                        Consultant in Regulatory Affairs specialising in Biologicals and Medical Devices                         -           Deavin Associates

SOCIETIES

• · Member of the Royal Pharmaceutical Society
• · Fellow of TOPRA (The Organisation for Professionals in Regulatory Affairs)
• · Member of the Chartered Management Institute
• · EC Qualified Person
• · Lead Assessor *ISO 9000 (Relevant to Pharmaceutical Raw Materials and Packaging) * Subject to continued registration through completion of requisite audits
  • Registered Teacher Status (RTS) Cranfield University

COMMITTEE ACTIVITIES Secretary:         Joint Pharmaceutical Analysis Group 1968-1985 TOPRA (previously BIRA) Medical Technology Steering Group1990-present (ex Chairman)

(Also lecturer at TOPRA Diploma courses for Regulatory students and a speaker at International meetings including the TOPRA Annual Symposium .)

Member:          Association of British Pharmaceutical Industry (ABPI) UK Regulatory Group 1984-1988, 1992 – 2000)

Member:          Regulatory Working Group 1 of The European Vaccine Manufacturers division of European Federation of Pharmaceutical Industry’s Associations (EFPIA) 1995-2000

Member: Cells and Tissues Working Group within EuropaBio.(Representing BIA at the Industry Stakeholders Consultation with the European Commission) 2004-2005

Initiator and Member of the Project Team for the Medical Technology Regulatory Affairs MSc at Cranfield University

Member TOPRA SPIN Steering Group Member 2000-Present

PRODUCT CATEGORY EXPERIENCE

• · Pharmaceuticals including Cardiovasculars, Topicals/Wound Healing, Anti-inflammatories, Psychotropics
• · Nutritionals
• · Vaccines/Biologicals
• · Contrast Media
• · Medical Devices including catheters, orthopaedic products, sutures, drug/device borderline, human tissue products.
• · Recombinant products.

Author of more than 50 publications in the Pharmaceutical Journal, Journal of Pharmacy and Pharmacology, BIRA Journal , Regulatory Review, ESRA Rapporteur and Regulatory Rapporteur